Press releases.

2026202520242023202220212020201920182017201620152014
Dec 16, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen further strengthens US market position with 1.5 MSEK order from global chemical industry leader
Nov 20, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen opens expanded laboratory facilities to strengthen capacity in line with 2030 growth plan
Nov 18, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
UK signals shift to non-animal testing – new opportunities for SenzaGen
Nov 12, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen secures order worth SEK 2.5 million from leading global tech company
Nov 10, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen presents growth plan and strategic priorities at Capital Markets Day
Nov 05, 2025
News
IR
English
Regulatory
MAR
Report
Interim
Q3
SenzaGen’s interim report January–September 2025 | Growth and break-even in Q3
Oct 29, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's Q3 2025 interim report
Oct 03, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen secures orders of SEK 1.3 million from a US-based world-leading chemical company
Sep 18, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen invites to Capital Markets Day in Stockholm on November 10, 2025
Aug 22, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen secures new follow-up order worth approx. 1.0 MSEK for GARD® from a global leading U.S. pharmaceutical company
Aug 20, 2025
News
IR
English
Regulatory
MAR
Report
Interim
Q2
SenzaGen’s interim report January–June 2025 | Strong order intake and expanded OECD approval for GARD®skin
Aug 14, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's Q2 2025 interim report
Jun 30, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen obtains expanded OECD approval for GARD®skin – further strengthens position in non-animal regulatory testing
Jun 24, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen receives new assignment worth 1.5 MSEK from RIFM for continued collaboration in photosensitization testing
Jun 02, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
SenzaGen receives new assignment from RIFM – confirms successful expansion of testing portfolio
May 14, 2025
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from AGM of SenzaGen AB on 14 May 2025
May 14, 2025
News
IR
English
Regulatory
MAR
Report
Interim
Q1
SenzaGen’s interim report January–March 2025: High activity amid global turbulence – building for growth
May 08, 2025
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Invitation to the presentation of SenzaGen's January-March 2025 interim report
Apr 22, 2025
News
IR
English
Corporate Information
Other Corporate Information
FDA signals shift towards non-animal testing in the pharmaceutical industry – strengthens SenzaGen’s commercial potential
Apr 11, 2025
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice of Annual General Meeting of SenzaGen AB (publ)
Next